OSRX INTRODUCES NEXT STEP IN SIMPLIFYING EYE CARE FOR DOCTORS AND THEIR PATIENTS
Ophthalmic Compounding Pharmacy Unveils Online Portal to Prescribe, Manage and Track Prescriptions
FOR IMMEDIATE RELEASE
Media Contact: Eric Garner, Ocular Science – (541) 413-2880; email@example.com
MANHATTAN BEACH, Calif. (May 12, 2020) – OSRX, the 503A compounding pharmacy affiliate of Southern California biotech Ocular Science®, today introduced an online portal designed to streamline and simplify the prescribing process. The OSRX Prescriber Portal, at osrxpharmaceuticals.com, is a simplified, secure process for submitting, tracking and managing patient scripts.
“Our organization was founded with a mission to provide easy-to-use, affordable, quality eye care medications in addition to exploring disruptive technologies that will change how doctors and patients view traditional medicine,” says Anthony Sampietro, co-founder and CEO of Ocular Science. “The OSRX Prescriber Portal is the next advancement in electronic prescriptions for eye care prescribers and patients across the country, who can now simply submit orders through our website. It’s a sleek, error-free process that’s a cinch to manage.”
OSRX Prescriber Portal Benefits:
Increased Control and Visibility
- Receive prescription confirmations, shipping notifications, delivery tracking and automated patient reminder calls
- Monitor prescription processing status from initial receipt to final delivery
- Review and approve refill requests
- Customizable preferences and medication presets create simplified process for submitting individual patient scripts
- Simplified large multi-patient orders by uploading surgery schedules/patient lists directly into the prescriber portal.
- Syncing your existing EMR system with the portal allows patient information to auto populate – reducing data entry for staff.
OSRX, a Pharmacy Compounding Accreditation Board-certified 503A facility based in Missoula, Mont., currently offers 13 combinations of customized eye drops and one intracameral injection for surgical vision correction, myopia treatment and the management of glaucoma. Marketed as “OMNI,” the patient-specific formulations combine multiple medications into a single dose to help simplify treatment, promote compliance and reduce out-of-pocket costs for patients.
“For doctors and their staff, the OSRX Prescriber Portal means much less data entry and far more control and visibility. For patients, it makes refilling and tracking their prescriptions much more convenient. It’s a game-changer,” says Sampietro.
For more information, visit osrxpharmaceuticals.com or email our team at firstname.lastname@example.org.
ABOUT OCULAR SCIENCE
Ocular Science, based in Manhattan Beach, Calif., with affiliate offices in Missoula, Mont. and Manhattan Beach, Calif., provides cost-effective, efficacious products to physicians and their patients for surgical vision correction, myopia and the management of glaucoma and dry eye disease. Founded in 2015 by CEO Anthony Sampietro, Chief Medical Officer Damien Goldberg, MD, and Francis Mah, MD, and led by a medical advisory board of world leaders in ophthalmology, the biotech company focuses on the production, marketing and sales of ophthalmic products. Ocular Science is divided into two standalone C corporations to supply quality products that are easy to use and promote compliance at reduced rates to patients: OSRX, the company’s 503A compounding pharmacy, supplies 13 combinations of medications in three areas of ophthalmology; and Regenerative Science, with amnion-derived biologics for dry eye disease management.